Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06436924 · ClinicalTrials.gov registry record

Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day

A clinical trial of Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.

Recruiting
Registry status
678
Enrollment target
7
Study locations

NCT06436924 is a study of Atrial Fibrillation that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 678 participants, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (77% lower). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06436924, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.

RECRUITING
Registry status
678 participants
Enrollment target
7
Study locations

Study Summary

SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE Left Atrial Appendage Device Implant

Study Locations (7)

Florida

  • Ascension St. Vincent - Jacksonville
  • Naples Community Hospital - Naples

Alabama

  • Grandview Medical Center - Birmingham

Arizona

  • Pima Heart and Vascular - Tucson

Colorado

  • The Medical Center of Aurora - Aurora

Georgia

  • Memorial Health University Medical Center - Savannah

South Carolina

  • Medical University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 678 participants
Start Date 2024-05-14
Est. Completion 2026-03-30

Sponsor

Heart Rhythm Clinical and Research Solutions

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06436924

The ClinicalTrials.gov registry entry for NCT06436924 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,994-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (77% lower). The listed sponsor is Heart Rhythm Clinical and Research Solutions, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Left Atrial Appendage Device Implant is the first listed.

NCT06436924 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Florida, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT06436924 about?

NCT06436924 is a clinical study titled "Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day". SAFE HV is an observational, prospective, multi-center, non-randomized study evaluating real-world clinical experience of centers where a single procedural physician schedules eight or more left atrial appendage occlusion (LAAO) device implant procedures in a single calendar day.

What is the current status of trial NCT06436924?

This trial is currently recruiting. The enrollment target is 678 participants. The study started on 2024-05-14. Estimated completion is 2026-03-30.

What conditions does trial NCT06436924 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT06436924?

The interventions under investigation include: Left Atrial Appendage Device Implant (DEVICE).

Who is sponsoring clinical trial NCT06436924?

This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06436924 being conducted?

This trial has 7 study locations across Alabama, Arizona, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.